医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) <i>versus</i> intercalated TKI with chemotherapy for <i>EGFR</i>-mutated nonsmall cell lung cancer.

广告
第一作者: Rolof G P,Gijtenbeek
第一单位: Dept of Respiratory Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
作者单位: Dept of Respiratory Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands. [1] Dept of Biometrics, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands. [2] Dept of Pulmonary Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands. [3] Dept of Respiratory Medicine, Hospital Group Twente, Almelo/Hengelo, The Netherlands. [4] Dept of Pulmonology, Leiden University Medical Centre, Leiden, The Netherlands. [5] Dept of Respiratory Medicine, Spaarne Hospital, Hoofddorp, The Netherlands. [6] Dept of Respiratory Medicine, Gelderse Vallei Hospital, Ede, The Netherlands. [7] Dept of Pulmonary Diseases, University of Groningen and University Medical Centre Groningen, Groningen, The Netherlands. [8] Dept of Pathology and Medical Biology, University of Groningen and University Medical Centre Groningen, Groningen, The Netherlands. [9] Dept of Respiratory Medicine, Máxima Medical Centre, Eindhoven/Veldhoven, The Netherlands. [10] Dept of Pulmonary Medicine, Gelre Hospitals, Zutphen, The Netherlands. [11] Dept of Respiratory Medicine, Maasstad Hospital, Rotterdam, The Netherlands. [12] Dept of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. [13] Dept of Respiratory Medicine, Isala Hospital, Zwolle, The Netherlands. [14] Dept of Pulmonary Diseases, Catharina Hospital, Eindhoven, The Netherlands. [15]
DOI 10.1183/23120541.00239-2022
PMID 36267895
发布时间 2024-02-09
提交
  • 浏览0
ERJ open research

ERJ open research

2022年8卷4期

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷